Andlauer Healthcare Group (TSE:AND – Get Free Report) had its price objective cut by stock analysts at CIBC from C$52.00 to C$50.00 in a research report issued to clients and investors on Monday, BayStreet.CA reports. The brokerage presently has an “outperform” rating on the stock. CIBC’s target price points to a potential upside of 23.21% from the company’s current price.
Several other research firms have also issued reports on AND. Eight Capital lowered their price target on Andlauer Healthcare Group from C$62.00 to C$58.00 and set a “buy” rating for the company in a research report on Thursday, March 7th. Scotiabank lifted their target price on shares of Andlauer Healthcare Group from C$45.00 to C$47.50 and gave the stock a “sector perform” rating in a report on Thursday, March 7th. National Bankshares increased their price target on shares of Andlauer Healthcare Group from C$46.00 to C$47.00 and gave the company a “sector perform” rating in a report on Thursday, March 7th. TD Securities decreased their price objective on shares of Andlauer Healthcare Group from C$54.00 to C$52.00 and set a “buy” rating for the company in a report on Monday. Finally, Stifel Nicolaus cut their target price on Andlauer Healthcare Group from C$55.00 to C$52.00 and set a “buy” rating on the stock in a research note on Monday. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, Andlauer Healthcare Group has an average rating of “Moderate Buy” and a consensus price target of C$49.43.
Get Our Latest Stock Analysis on AND
Andlauer Healthcare Group Price Performance
Andlauer Healthcare Group (TSE:AND – Get Free Report) last posted its quarterly earnings data on Tuesday, March 5th. The company reported C$0.44 earnings per share for the quarter, missing analysts’ consensus estimates of C$0.49 by C($0.05). Andlauer Healthcare Group had a net margin of 10.21% and a return on equity of 14.53%. The company had revenue of C$169.07 million for the quarter, compared to the consensus estimate of C$165.00 million. Analysts expect that Andlauer Healthcare Group will post 1.8439434 EPS for the current fiscal year.
About Andlauer Healthcare Group
Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.
Recommended Stories
- Five stocks we like better than Andlauer Healthcare Group
- The 3 Best Blue-Chip Stocks to Buy Now
- Garmin Navigates to New Highs Driven By Wearables Trend
- What is the FTSE 100 index?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- ESG Stocks, What Investors Should Know
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.